{"id":"doi:10.1370/afm.3050","kind":"review","title":"Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis","authors":["Mark H. Ebell","Henry C Barry","Kanishka Baduni","Gabrielle Grasso"],"author_count":4,"year":2024,"published":"2024-01-01","venue":"The Annals of Family Medicine","cited_by":100,"doi":"10.1370/afm.3050","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1370/afm.3050","archive_url":"https://space-kitty.com/papers/doi:10.1370/afm.3050","updated":null,"pmid":"38253509","pmcid":null,"openalex_id":"W4391116469","pdf_url":"https://www.annfammed.org/content/annalsfm/22/1/50.full.pdf","abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Alzheimer's disease research and treatments"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"neurodegeneration","name":"Alzheimer's, Parkinson's & Neurodegeneration","domain_slug":"medicine"}],"cited_in_dossiers":[]}